AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Shapiro, CL Manola, J Leboff, M
Citation: Cl. Shapiro et al., Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer, J CL ONCOL, 19(14), 2001, pp. 3306-3311

Authors: Shapiro, CL Recht, A
Citation: Cl. Shapiro et A. Recht, Drug therapy - Side effects of adjuvant treatment of breast cancer, N ENG J MED, 344(26), 2001, pp. 1997-2008

Authors: Jacobson, AF Shapiro, CL Van den Abbeele, AD Kaplan, WD
Citation: Af. Jacobson et al., Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma, CANC CYTOP, 91(1), 2001, pp. 17-24

Authors: Jacobson, AF Shapiro, CL Van den Abbeele, AD Kaplan, WD
Citation: Af. Jacobson et al., Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma, CANCER, 91(1), 2001, pp. 17-24

Authors: Guadagnoli, E Soumerai, SB Gurwitz, JH Borbas, C Shapiro, CL Weeks, JC Morris, N
Citation: E. Guadagnoli et al., Improving discussion of surgical treatment options for patients with breast cancer: local medical opinion leaders versus audit and performance feedback, BREAST CANC, 61(2), 2000, pp. 171-175

Authors: Oh, WK Manola, J Renshaw, AA Brodkin, D Loughlin, KR Richie, JP Shapiro, CL Kantoff, PW
Citation: Wk. Oh et al., Smoking and alcohol use may be risk factors for poorer outcome in patientswith clear cell renal carcinoma, UROLOGY, 55(1), 2000, pp. 31-35

Authors: Shapiro, CL Keating, J Angell, JE Janicek, M Gelman, R Hayes, D LeBoff, MS
Citation: Cl. Shapiro et al., Monitoring therapeutic response in skeletal metastases using dual-energy X-ray absorptiometry: A prospective feasibility study in breast cancer patients, CANCER INV, 17(8), 1999, pp. 566-574

Authors: Shapiro, CL
Citation: Cl. Shapiro, Doxorubicin cardiotoxicity: Growing importance - Reply 1, J CL ONCOL, 17(7), 1999, pp. 2295-2296

Authors: Shapiro, CL Ervin, T Welles, L Azarnia, N Keating, J Hayes, DF
Citation: Cl. Shapiro et al., Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer, J CL ONCOL, 17(5), 1999, pp. 1435-1441
Risultati: 1-9 |